Evidence map›Paper›PMID 42575282›Full record

ArticleJournal of lipid research2026

Cannabidiol attenuates atherosclerosis in male ApoE

Monika Cahová, Elisabeth Ableitner, Kamila Bechyňská, Štěpánka Kučková, Jitka Viktorová, Viktória Mikušová, Vít Kosek, Zuzana Bínová, František Beneš, Ondřej Fabián and 9 more

Abstract read
In one paragraph

Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Monika CahováCentre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Elisabeth AbleitnerDepartment of Pharmacology and Toxicology, University of Graz, Graz, Austria.
Kamila BechyňskáDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic.
Štěpánka KučkováDepartment of Biochemistry and Microbiology, University of Chemical Technology, Prague, Czech Republic.
Jitka ViktorováDepartment of Biochemistry and Microbiology, University of Chemical Technology, Prague, Czech Republic.
Viktória MikušováDepartment of Data Science, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Vít KosekDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic.
Zuzana BínováDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic.
František BenešDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic.
Ondřej FabiánDepartment of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Ondřej StrnadDepartment of Biochemistry and Microbiology, University of Chemical Technology, Prague, Czech Republic.
Tomáš NejedlýDepartment of Biochemistry and Microbiology, University of Chemical Technology, Prague, Czech Republic.
Marie HeczkováCentre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Miriam BrátováCentre of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Petr KaštánekDepartment of Biotechnology, University of Chemical Technology, Prague, Czech Republic.
Martin MalýCardiac Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Jana HajšlováDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic.
Marion MussbacherDepartment of Pharmacology and Toxicology, University of Graz, Graz, Austria.
Milena StránskáDepartment of Food Analysis and Nutrition, University of Chemistry and Technology, Prague, Czech Republic. Electronic address: milena.stranska@vscht.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol (CBD), a non-psychoactive phytocannabinoid from Cannabis sativa, exhibits anti-inflammatory and antioxidant properties. We therefore hypothesized that CBD may modulate atherosclerosis development; however, preclinical evidence remains limited and sex-specific effects are poorly understood. Male and female apolipoprotein E-deficient (ApoE

Indexed as

AtherosclerosisCannabidiolLipidomicsProteomicsSex differences

Identifiers

PMID42575282
PMCPMC13586724

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.